Vivani Medical Inc expected to post a loss of 8 cents a share - Earnings Preview

Vivani Medical

07/08/2026 16:10

Vivani Medical Inc VANI.OQ VANI.O is expected to  show no change in quarterly revenue when it reports  results on August 11 (estimated) for the period ending June 30 2026

​LSEG's mean analyst estimate for Vivani Medical Inc is for a loss of 8 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Vivani Medical Inc is $4.00, about 194.1% above its last closing price of $1.36
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.08
-0.08
-0.08
Met
0
Dec. 31 2026
-0.10
-0.09
Beat
10
Sep. 30 2025
-0.12
-0.11
-0.11
Met
0​
Jun. 30 2025
-0.10
-0.10
-0.12
Missed
-20
​​Mar. 31 2025
-0.11
-0.10
-0.11
Missed
-4.8
Dec. 31 2024
-0.11
-0.11
Met
0​
Sep. 30 2024
-0.10
-0.11
-0.11
Met
4.3
Jun. 30 2024
-0.12
-0.10
Beat
16.7
This summary was machine generated August 7 at 15:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)